Matches in UGent Biblio for { <https://biblio.ugent.be/publication/5638213#aggregation> ?p ?o. }
Showing items 1 to 42 of
42
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B839315.
- aggregation creator B839316.
- aggregation creator B839317.
- aggregation creator B839318.
- aggregation creator B839319.
- aggregation creator B839320.
- aggregation creator B839321.
- aggregation creator B839322.
- aggregation creator B839323.
- aggregation creator B839324.
- aggregation creator B839325.
- aggregation creator person.
- aggregation date "2013".
- aggregation format "application/pdf".
- aggregation hasFormat 5638213.bibtex.
- aggregation hasFormat 5638213.csv.
- aggregation hasFormat 5638213.dc.
- aggregation hasFormat 5638213.didl.
- aggregation hasFormat 5638213.doc.
- aggregation hasFormat 5638213.json.
- aggregation hasFormat 5638213.mets.
- aggregation hasFormat 5638213.mods.
- aggregation hasFormat 5638213.rdf.
- aggregation hasFormat 5638213.ris.
- aggregation hasFormat 5638213.txt.
- aggregation hasFormat 5638213.xls.
- aggregation hasFormat 5638213.yaml.
- aggregation isPartOf urn:issn:0392-856X.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study".
- aggregation abstract "Objective. To determine the clinical characteristics of simultaneous occurrence of antitopoisomerase (ATA) and anticentromere (ACA) autoantibodies in systemic sclerosis (SSc). Methods. Data of patients (n=4,687) fulfilling the ACR criteria for SSc and followed in the EULAR Scleroderma Trials and Research (EUSTAR) cohort were analysed. Sera from patients with simultaneous ATA and ACA were reanalysed centrally by indirect immunofluorescence, enzyme immunoassay, and immunoblot to confirm antibody status. Results. A total of 29 patients (0.6%) had been documented double-positive for both ATA and ACA in the EUSTAR database. Sera of 14 cases were available for central analysis, of which 8 were confirmed to unequivocally contain both antibodies. The double-positive patients were on average 52.4 years of age, 87.5% were female, and 62.5% had diffuse cutaneous (dc) SSc. Compared with matched ACA single-positive disease, cutaneous and visceral complications were more prevalent in double-positive cases, but this prevalence did not differ significantly in comparison to ATA single-positives. Conclusions. Coexistence of ATA and ACA can be found at low prevalence in SSc. The clinical features of double-positive patients are not clearly dissimilar to those of patients harbouring only ATA. The data do not support a direct involvement of these antibodies in the pathogenesis of established SSc, but may lack statistical power.".
- aggregation authorList BK1214957.
- aggregation endPage "S102".
- aggregation issue "2, suppl. 76".
- aggregation startPage "S96".
- aggregation volume "31".
- aggregation aggregates 5638226.
- aggregation isDescribedBy 5638213.
- aggregation similarTo LU-5638213.